$12.24
0.33% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
US05368M1062
Symbol
CDMO

Avid Bioservices, Inc. Stock price

$12.24
-0.11 0.89% 1M
+5.23 74.61% 6M
+5.74 88.31% YTD
+5.49 81.33% 1Y
-18.03 59.56% 3Y
+4.18 51.86% 5Y
+2.02 19.77% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.04 0.33%
ISIN
US05368M1062
Symbol
CDMO
Sector

Key metrics

Market capitalization $782.91m
Enterprise Value $954.81m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.35
P/S ratio (TTM) P/S ratio 5.20
P/B ratio (TTM) P/B ratio 17.47
Revenue growth (TTM) Revenue growth 6.75%
Revenue (TTM) Revenue $150.45m
EBIT (operating result TTM) EBIT $-20.38m
Free Cash Flow (TTM) Free Cash Flow $-9.68m
Cash position $35.12m
EPS (TTM) EPS $-2.39
P/E forward negative
P/S forward 4.80
EV/Sales forward 5.85
Short interest 18.40%
Show more

Is Avid Bioservices, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Avid Bioservices, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Avid Bioservices, Inc. forecast:

4x Hold
100%

Analyst Opinions

4 Analysts have issued a Avid Bioservices, Inc. forecast:

Hold
100%

Financial data from Avid Bioservices, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '24
+/-
%
150 150
7% 7%
100%
- Direct Costs 139 139
13% 13%
92%
12 12
35% 35%
8%
- Selling and Administrative Expenses 19 19
5% 5%
13%
- Research and Development Expense - -
-
-
-7.54 -7.54
1,408% 1,408%
-5%
- Depreciation and Amortization 13 13
39% 39%
9%
EBIT (Operating Income) EBIT -20 -20
109% 109%
-14%
Net Profit -152 -152
1,190% 1,190%
-101%

In millions USD.

Don't miss a Thing! We will send you all news about Avid Bioservices, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Avid Bioservices, Inc. Stock News

Neutral
Business Wire
about 10 hours ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avid Bioservices, Inc. (NASDAQ: CDMO) to funds managed by GHO Capital Partners LLP and Ampersand Capital Partners for $12.50 per share in cash is fair to Avid shareholders. Halper Sadeh encourages Avid shareholders to click here to learn more about their legal rights and options or con...
Neutral
GlobeNewsWire
10 days ago
TUSTIN, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it has commenced mailing definiti...
Neutral
GlobeNewsWire
18 days ago
TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the second quarter and six months ended Octo...
More Avid Bioservices, Inc. News

Company Profile

Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Head office United States
CEO Nicholas Green
Employees 371
Founded 1981
Website avidbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today